ALNY icon

Alnylam Pharmaceuticals

168 hedge funds and large institutions have $3.58B invested in Alnylam Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 61 increasing their positions, 65 reducing their positions, and 27 closing their positions.

Holders
168
Holders Change
+4
Holders Change %
+2.44%
% of All Funds
4.88%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.12%
New
31
Increased
61
Reduced
65
Closed
27
Calls
$7.17M
Puts
$11.1M
Net Calls
-$3.93M
Net Calls Change
-$8.69M
Name Market Value Shares Shares
Change
Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$612M 9,512,811 +70,011 +0.7%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$524M 8,147,876 +6,085,029 +295%
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$245M 3,814,045 -422,690 -10%
Vanguard Group
4
Vanguard Group
Pennsylvania
$191M 2,967,253 +130,410 +5%
BFA
5
BlackRock Fund Advisors
California
$142M 2,213,522 -35,480 -2%
Franklin Resources
6
Franklin Resources
California
$138M 2,144,110 +100,470 +5%
CWAM
7
Columbia Wanger Asset Management
Illinois
$123M 1,910,000 +595,144 +45%
GGHC
8
Gilder Gagnon Howe & Co
New York
$122M 1,899,152 -21,926 -1%
UBS AM
9
UBS AM
Illinois
$102M 1,586,502 +360,743 +29%
BIT
10
BlackRock Institutional Trust
California
$95.7M 1,489,038 +809 +0.1%
State Street
11
State Street
Massachusetts
$91M 1,415,406 -112,432 -7%
Capital World Investors
12
Capital World Investors
California
$67.8M 1,054,700 -158,300 -13%
Jennison Associates
13
Jennison Associates
New York
$65.5M 1,018,156 -113,782 -10%
SPC
14
Slate Path Capital
New York
$64.3M 1,000,000 -260,000 -21%
AWG
15
Alpha Wave Global
New York
$64.3M 1,000,000 +1,000,000 New
Wells Fargo
16
Wells Fargo
California
$64.1M 997,534 +30,365 +3%
Baillie Gifford & Co
17
Baillie Gifford & Co
United Kingdom
$57.5M 893,100 +140,100 +19%
Northern Trust
18
Northern Trust
Illinois
$52.8M 820,785 +15,307 +2%
Morgan Stanley
19
Morgan Stanley
New York
$47.7M 741,565 +550,847 +289%
CCI
20
Columbus Circle Investors
$42.3M 658,309 -300,008 -31%
TCM
21
TimesSquare Capital Management
New York
$38.8M 602,900 -19,900 -3%
BB
22
BB Biotech
Switzerland
$30.3M 471,288
Artisan Partners
23
Artisan Partners
Wisconsin
$28.5M 443,722 +20,899 +5%
Goldman Sachs
24
Goldman Sachs
New York
$28.3M 440,750 +91,961 +26%
BM
25
Bridger Management
New York
$28.3M 440,000 -3,181 -0.7%